Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 07/22 10:00:00 pm
78.86 USD   +0.34%
07/23 EXPRESS SCRIPTS : Announces Early Tender Results and Upsizing of Max..
07/15 EXPRESS SCRIPTS : Clearent Appoints New Chief Financial Officer
07/15 EXPRESS SCRIPTS : Announces Pricing of Maximum Tender Offers
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at jon.kamp@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
07/23 EXPRESS SCRIPTS : Announces Early Tender Results and Upsizing of Maximum Tender ..
07/15 EXPRESS SCRIPTS : Clearent Appoints New Chief Financial Officer
07/15 EXPRESS SCRIPTS HOLDING CO. : Other Events, Financial Statements and Exhibits (f..
07/15 EXPRESS SCRIPTS : Announces Pricing of Maximum Tender Offers
07/14 EXPRESS SCRIPTS : Clearent Appoints New Chief Financial Officer
07/14 EXPRESS SCRIPTS : Announces Early Tender Results and Upsizing of Maximum Tender ..
07/14 EXPRESS SCRIPTS : Pharmacists question audit process that denies payments
07/11 Express Scripts Holding Company Announces Second Quarter Earnings Conference ..
07/07 VERINT SYSTEMS : Presents New York Life and Express Scripts with 2016 Engage Glo..
07/07 EXPRESS SCRIPTS HOLDING CO. : Other Events, Financial Statements and Exhibits (f..
More news
Sector news : Drug Retailers - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/21DJSINOPHARM : to Inject Certain Assets Into China National Medicines for CNY5.37 B..
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
More sector news : Drug Retailers - NEC
News from SeekingAlpha
07/24 Notable earnings after Monday?s close
07/20 United Health Today, Centene And Humana Tomorrow
07/13 BLUE TOWER Q2 2016 LETTER TO CLIENTS : Updated Theses For Express Scripts And EZ..
07/11 A REVIEW OF THE COMPONENTS OF THE IS : Regeneron Pharmaceuticals
07/06 Express Scripts prices tender offer for 2017 debt; $1.105B tendered
Advertisement
Financials ($)
Sales 2016 102 124 M
EBIT 2016 6 407 M
Net income 2016 2 945 M
Debt 2016 12 437 M
Yield 2016 -
P/E ratio 2016 17,09
P/E ratio 2017 15,66
EV / Sales 2016 0,61x
EV / Sales 2017 0,58x
Capitalization 49 903 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 81,5 $
Spread / Average Target 3,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-9.78%49 903
CVS HEALTH CORP-1.25%103 697
WALGREENS BOOTS ALLIAN..-4.47%88 047
MCKESSON CORPORATION-0.33%44 365
CARDINAL HEALTH INC-7.03%27 039
AMERISOURCEBERGEN CORP..-17.21%18 533
More Results